Eliyahu Sharon Kalif - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Financial Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif
Issuer symbol
TEVA
Transactions as of
03 Mar 2023
Net transactions value
$0
Form type
4
Filing time
07 Mar 2023, 15:10:42 UTC
Previous filing
02 Mar 2023
Next filing
09 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +33,512 +42% 112,900 04 Mar 2023 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +21,387 +19% 134,287 05 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +199,202 $0.000000 199,202 03 Mar 2023 Ordinary Shares 199,202 Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -33,512 -25% $0.000000 100,536 04 Mar 2023 Ordinary Shares 33,512 Direct F1, F2, F4
transaction TEVA Restricted Share Units Options Exercise $0 -21,387 -33% $0.000000 42,777 05 Mar 2023 Ordinary Shares 21,387 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 3, 2023, with 49,800 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 49,802 vesting on March 3, 2027.
F4 Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
F5 Restricted share units were granted on March 5, 2021, with 21,387 vested on each of March 5, 2022 and March 5, 2023, 21,387 vesting on March 5, 2024, and 21,390 vesting on March 5, 2025.